Your basket is currently empty!
New biomarkers for RCC subtypes improving diagnosis & treatment
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis ...
News Archive
Clinical Trials
Pharma’s partner for phase Ib of RCC trial
Merck partners with HiberCell for Phase Ib renal carcinoma trial
The Phase Ib trial will evaluate the ...
Clinical Trial News – PEAR-TREE 2
Exploring how to match treatments to patients
Patients with advanced or metastatic kidney cancer now have a range ...
National Cancer Research Institute (NCRI) to close
The National Cancer Research Institute (NCRI) has announced that it will be winding down its operations prior to ...
ALLO-316 Demonstrates Antitumor Activity in Advanced ccRCC
Data Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma ...
No results found.